Figure 1: Flow diagram of establishing the study cohorts and cross-sectional samples followed by matching on clinical characteristics and propensity scores for patients under hemodialysis (HD) and peritoneal dialysis (PD) to estimate quality-adjusted life expectancy (QALE) and lifetime costs. | Scientific Reports

Figure 1: Flow diagram of establishing the study cohorts and cross-sectional samples followed by matching on clinical characteristics and propensity scores for patients under hemodialysis (HD) and peritoneal dialysis (PD) to estimate quality-adjusted life expectancy (QALE) and lifetime costs.

From: Cost-effectiveness of hemodialysis and peritoneal dialysis: A national cohort study with 14 years follow-up and matched for comorbidities and propensity score

Figure 1

Abbreviation: ESRD: end-stage renal disease; QALE: quality-adjusted life expectancy; QALY: quality-adjusted life year.

Back to article page